National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia

Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E

Past Highlights
   
 
Results: 1 -10 of 303         results per page
View Search Criteria | Help With Results
           

1.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Diagnostic, Treatment


Active


18 to 85


Other


COLOGEN
NCT00138060


2.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Biomarker/Laboratory analysis, Treatment


Active


18 to 75


Other


ASSO OE-1
EudraCT 2006-006647-31, NCT00525200

First Published: 11/14/2007  

3.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Biomarker/Laboratory analysis, Treatment


Active


18 and over


Other


CHUL-BIO-COLON
RECF0356, INCA-RECF0356, NCT00559676


4.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 to 70


Pharmaceutical / Industry


CMNa-ESO-01-2007
NCT00642239


5.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Treatment


Active


18 and over


Other


YUNZHI-BC
NCT00647075


6.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase IV


Supportive care


Active


18 to 85


Other


GLU_07
NCT00772824

Last Modified: 6/15/2007     First Published: 5/23/2005  

7.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


18 to 75


Other


FRE-FNCLCC-ACCORD-11/0402
EU-20512, NCT00112658

Last Modified: 2/15/2007     First Published: 3/13/2006  

8.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


18 and over


Other, Pharmaceutical / Industry


FFCD-9902
SANOFI-FFCD-9902, LILLY-FFCD-9902, FFCD-FNCLCC-SFRO-9902, NCT00304135


9.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


D8480C00013
Eudract Number 2005-003440-66, NCT00384176


10.

Phase
Type
Status
Age
Sponsor
Protocol IDs

Phase III, Phase II


Treatment


Active


18 and over


Pharmaceutical / Industry


STX0206
NCT00724503

   
    1 2 3 4   Next >

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov